Similarly, in studies of prostate cancer, a shared genetic basis between prostate specific antigen, repeatedly measured for patients following treatment for prostate cancer, and the time to disease recurrence can be used to make optimal treatment schedules for patients. Here, KLK3 is linked to prostate cancer.